Heart Disease News and Research

Latest Heart Disease News and Research

LUMEDX announces subscription of 50 hospitals to cardiovascular SaaS solution

LUMEDX Corporation, a leading provider of vendor-neutral, integrated medical imaging and information systems, announced today that 50 hospitals now subscribe to its cardiovascular software-as-a-service (SaaS) solution. LUMEDX's SaaS delivery model allows clients to access and utilize software remotely via the web — resulting in faster implementations and lower licensing, maintenance and personnel costs. The service also includes built-in disaster recovery and high-intensity security systems.

21 Dec 2010

Cambridge Heart completes private placement

Cambridge Heart, Inc., developer of non-invasive diagnostic tests for cardiac disease, today announced that on December 20, 2010 it completed a private placement to accredited investors. The transaction raised gross proceeds of $2.9 million and consisted of Units that were comprised of one share of common stock and a warrant to purchase one share of common stock.

21 Dec 2010

Genzyme provides information on peak sale of alemtuzumab for multiple sclerosis

Genzyme Corporation today provided an extensive briefing on the market potential of alemtuzumab for multiple sclerosis at an event for investors and analysts in New York.

21 Dec 2010

Researchers present definitive explanation of how fibrotic cells destroy human liver

In the latest of a series of related papers, researchers at the University of California, San Diego School of Medicine, with colleagues in Austria and elsewhere, present a new and more definitive explanation of how fibrotic cells form, multiply and eventually destroy the human liver, resulting in cirrhosis. In doing so, the findings upend the standing of a long-presumed marker for multiple fibrotic diseases and reveal the existence of a previously unknown kind of inflammatory white blood cell.

21 Dec 2010

Group buy program helps hospitals save $81 million

Over the past year, 1,220 hospitals participating in the Premier healthcare alliance's group buy program have identified $81 million in savings through access to high-quality products at low costs.

21 Dec 2010

DNA sequence variations linked with heart's electrical rhythm in several surprising regions

A study among almost 50,000 people worldwide has identified DNA sequence variations linked with the heart's electrical rhythm in several surprising regions among 22 locations across the human genome. The variants were found by an international consortium, including Johns Hopkins researchers, and reported Nov. 14 in the Nature Genetics advance online publication.

21 Dec 2010

Magellan, ACG partner to train specialists to provide Peer Support Whole Health services

Magellan Health Services, Inc., an industry leader in behavioral health care management, and Appalachian Consulting Group (ACG) have joined forces to train peer specialists to provide Peer Support Whole Health (PSWH) services. PSWH, an evidence-based behavioral health practice that is growing in use across the country, focuses on improving the overall physical and mental health of individuals with mental illnesses to help them achieve their health and wellness goals.

21 Dec 2010

Silence provides year-end update on trading and offer-period

Silence Therapeutics plc, a leading global biotechnology company dedicated to the discovery, development and delivery of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases, today provides a year-end update on trading and the offer-period.

21 Dec 2010

New research sheds light on complex regulatory pathways for effective innate immune system

New research by scientists at the University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences reveals that the immune system has an effective backup plan to protect the body from infection when the "master regulator" of the body's innate immune system fails.

21 Dec 2010

Scientists boost protein supply to enhance muscle function, reduce nerve-dependent fatigue in mice

Researchers at Vanderbilt University have "engineered" a mouse that can run on a treadmill twice as long as a normal mouse by increasing its supply of acetylcholine, the neurotransmitter essential for muscle contraction.

21 Dec 2010

Researchers show how malaria parasites infect red blood cells, impede blood flow to organs

Although the incidence of malaria has declined in all but a few countries worldwide, according to a World Health Organization report earlier this month, malaria remains a global threat. Nearly 800,000 people succumbed to the mosquito-borne disease in 2009, nearly all of them in the developing world.

21 Dec 2010

Brilinta – AstraZeneca’s new blood thinner faces FDA hurdle

AstraZeneca’s new blood thinner that was pitched against Plavix, the world’s second-best selling drug failed to live up to expectations making stocks drop to a two year low, the steepest decline since Nov. 21, 2008, and the worst performance today on the 18-company Bloomberg Europe Pharmaceutical Index.

20 Dec 2010

The health law and legal challenges: What the future holds

News outlets continue their efforts to handicap the health law's chances as it progresses through the judicial system toward the Supreme Court. Meanwhile, The New York Times reports on a proposal — inspired by such repeal efforts — for a Constitutional amendment that would allow states to overturn federal laws passed by Congress.

20 Dec 2010

Health overhaul roundup: Analyzing the individual mandate, watching the politics around reform

While last week's biggest news focused on the court action surrounding the health law, some reports now analyze the controversial provision at the heart of these cases and what the future could look like if it did or did not survive. But reform news also translates into political news, as PolitiFact pinpoints its "Lie of the Year" and the Atlanta Journal Constitution reports on how federal reforms could influence the state's gubernatorial election.

20 Dec 2010

Opsens unveils EasyWire for growth market of Fractional Flow Reserve for coronary lesion assessment

Opsens Inc. today unveiled the EasyWire, developed by its medical division for the growth market of Fractional Flow Reserve for coronary lesion assessment.

20 Dec 2010

Spartan RX CYP2C19 DNA testing system receives European CE Mark certification

Spartan Bioscience Inc., a privately held molecular diagnostics company that develops, manufactures, and markets DNA testing systems for on-demand applications, today announced its Spartan RX CYP2C19 received a CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices. The CE Mark certification allows commercial distribution in Europe as well as in all countries recognizing the CE Mark in the Middle East, Africa, Latin America, and Asia-Pacific regions.

20 Dec 2010

Itamar Medical, Roche enter development agreement for EndoPAT device

Itamar Medical, the leader in non-invasive vascular health diagnostics, announced today that an agreement has been signed with Roche by which Itamar will develop an EndoPAT device designated for use with animal models, enabling pre-clinical studies examining the efficacy of various compounds in the early stage of drug development essential for later stage development in humans.

20 Dec 2010

First Edition: December 20, 2010

Today's headlines include more analysis on the continuing legal challenges to the health law and the path they might take to the Supreme Court.

20 Dec 2010

MEDNAX acquires Neonatology Associates in Kingsport

MEDNAX, Inc., today announced the acquisition of a neonatal physician group based in Kingsport, TN.

20 Dec 2010

Response Biomedical strengthens patent protection for RAMP technology

Response Biomedical Corporation today announced that the United States Patent and Trademark Office issued an official Notice of Allowance on one of the Company's patent applications regarding the RAMP® technology. The patent entitled "Comparative Multiple Analyte Immunoassay" is expected to issue in the first quarter of 2011.

20 Dec 2010

Heart Disease News and Research

Latest Heart Disease News and Research

LUMEDX announces subscription of 50 hospitals to cardiovascular SaaS solution

Cambridge Heart completes private placement

Genzyme provides information on peak sale of alemtuzumab for multiple sclerosis

Researchers present definitive explanation of how fibrotic cells destroy human liver

Group buy program helps hospitals save $81 million

DNA sequence variations linked with heart's electrical rhythm in several surprising regions

Magellan, ACG partner to train specialists to provide Peer Support Whole Health services

Silence provides year-end update on trading and offer-period

New research sheds light on complex regulatory pathways for effective innate immune system

Scientists boost protein supply to enhance muscle function, reduce nerve-dependent fatigue in mice

Researchers show how malaria parasites infect red blood cells, impede blood flow to organs

Brilinta – AstraZeneca’s new blood thinner faces FDA hurdle

The health law and legal challenges: What the future holds

Health overhaul roundup: Analyzing the individual mandate, watching the politics around reform

Opsens unveils EasyWire for growth market of Fractional Flow Reserve for coronary lesion assessment

Spartan RX CYP2C19 DNA testing system receives European CE Mark certification

Itamar Medical, Roche enter development agreement for EndoPAT device

First Edition: December 20, 2010

MEDNAX acquires Neonatology Associates in Kingsport

Response Biomedical strengthens patent protection for RAMP technology

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in